Study of fatty liver in adults in China
Part of Digestive system clinical trials.
This study follows adults with fatty liver to learn more about how it progresses and what patterns are common. It may help improve future ways of identifying and monitoring fatty liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with fatty liver (hepatic steatosis) based on a scan or test
- You must have at least one confirming result, such as a “bright liver” on ultrasound, high CAP on a specialized ultrasound test, fatty liver on CT/MRI/MRS, or higher liver fat on MRI-PDFF
- You have not been diagnosed with liver cancer or another active cancer
- You are not pregnant
- You have never had a liver transplant
- You have not had serious recent heart or stroke problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a long-term study that follows adults who are being managed for fatty liver (NAFL) or NASH to learn how these conditions change over time. It may help researchers better understand what to expect and how care decisions could be improved.
This study follows people who have chronic hepatitis B and also have fat buildup in the liver (nonalcoholic fatty liver disease). It’s looking at how these conditions behave over time and what may help, using information collected during follow-up visits.
This study looks at adults with different long-term liver conditions that are associated with fatty liver. It helps researchers better understand these diseases and factors linked to them.
This study follows people with fatty liver disease (NAFLD) and a related condition (NASH) to see how it changes over time. It may help researchers understand who is most likely to worsen and what patterns show up as the disease progresses.
This study follows people with nonalcoholic fatty liver disease to better understand the condition. It uses an MRI scan and collects body samples to help researchers study changes over time.
This trial is testing a new ultrasound method to measure fat in the liver for people with metabolic fatty liver disease (MAFLD). It may help understand how well ultrasound can show liver fat compared to a liver biopsy or MRI.
Hear when a new Metabolic Associated Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.